I promise

"I promise, Suzy... Even if it takes the rest of my life." -Nancy G. Brinker, Founder of Susan G. Komen for the Cure

What is TNBC

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer (TNBC) has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" of breast cancer. Being Triple Negative, you don't have a targeted therapy and your only treatment option is chemotherapy.

Triple Negative Breast Cancer is seen in about 15% of all breast cancers. TNBC is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TNBC is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Tuesday, January 26, 2021

The University of Toledo's Researcher, Dr. Amit Tiwari Awarded $1.4 Million to Advance Research in Promising New Chemotherapy for Triple Negative Breast Cancer

 

Melissa Paskvan 
and Dr. Tiwari
My TNBC researcher here in Toledo was just awarded another grant, this time from U.S. Department of Defense for $1.4 million to further his research in overcoming drug resistance in treatment therapy in Triple Negative Breast Cancer.  I am so proud to be a part of University of Toledo's Dr. Amit Tiwari's research team as their Patient Advocate Mentor for continued research on Triple Negative Breast Cancer.  Congratulations to D. Tiwari and his amazing team! I am glad that we found each other as partners in this fight against TNBC!

(Click link to story) 

UToledo Awarded $1.4 Million to Advance New Chemotherapy for Difficult-to-Treat Breast Cancer


"We are glad that you are part of our team.  Thank you for your wonderful spirit and passion to keep us moving forward." - Dr. Amit K. Tiwari


Total Pageviews



"click image to link"